{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:08Z","timestamp":1772165588260,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This retrospective study aimed to compare the outcomes of sutureless aortic valve replacement (su-AVR) and conventional bioprosthetic sutured AVR (cAVR) in high-risk patients undergoing redo surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 79 patients who underwent redo AVR between 2014 and 2021 were included in the study. Of these, 27 patients underwent su-AVR and 52 underwent cAVR. Patient characteristics and clinical outcomes were analysed using multivariate regression and Kaplan Meier survival test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The groups were similar in terms of age, gender, left ventricular function, and number of previous sternotomies. In cases of isolated AVR, su-AVR had significantly lower cross clamp times than cAVR (71 vs. 86\u00a0min,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03). Postoperatively, 4 cAVR patients required pacemaker compared to zero patients in the su-AVR group. There were no significant differences between the two groups in terms of postoperative complications, intrahospital stay (median 9\u00a0days, IQR 7\u201320), or in-hospital mortality (1 su-AVR; 2 cAVR). The long-term survival rate was similar between the su-AVR (90%) and cAVR (92%) groups (log rank\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.8). The transvalvular gradients at follow-up were not affected by the type of valve used, regardless of the valve size (coef 2.68, 95%CI -3.14\u20138.50,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.36).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study suggests that su-AVR is a feasible and safe alternative to cAVR in high-risk patients undergoing redo surgery. The use of su-AVR offers comparable outcomes to cAVR, with reduced cross clamp times and a lower incidence of postoperative pacemaker requirement in isolated AVR cases. The results of this study contribute to the growing body of evidence supporting the use of su-AVR in high-risk patients, highlighting its feasibility and safety in redo surgeries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03652-7","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:13:48Z","timestamp":1704298428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sutureless Biological Aortic Valve Replacement (Su-AVR) in Redo operations: a retrospective real-world experience report of clinical and echocardiographic outcomes"],"prefix":"10.1186","volume":"24","author":[{"given":"Ian","family":"Cummings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Yousuf","family":"Salmasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil Ibrahim","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Zientara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"AlShiekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Asimakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"3652_CR1","doi-asserted-by":"crossref","unstructured":"Holinski S, Jessen S, Neumann K, Konertz W. Predictive power and implication of EuroSCORE, EuroSCORE II and STS score for isolated repeated aortic valve replacement. Ann Thorac Cardiovasc Surg. 2015;","DOI":"10.1055\/s-0034-1367326"},{"key":"3652_CR2","doi-asserted-by":"crossref","unstructured":"Morales D, Williams E, John R. Is resternotomy in cardiac surgery still a problem? Interact Cardiovasc Thorac Surg. 2010;","DOI":"10.1510\/icvts.2009.232090"},{"key":"3652_CR3","doi-asserted-by":"crossref","unstructured":"Sedeek AF, Greason KL, Sandhu GS, Dearani JA, Holmes DR, Schaff H V. Transcatheter Valve-in-Valve Vs Surgical Replacement of Failing Stented Aortic Biological Valves. Ann Thorac Surg. 2019;","DOI":"10.1016\/j.athoracsur.2019.03.084"},{"key":"3652_CR4","doi-asserted-by":"crossref","unstructured":"Dokollari A, Cameli M, Mandoli GE, Kalra DKS, Poston R, Coku L, et al, 2021. Early and midterm clinical outcomes of transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement for aortic bioprosthetic valve degeneration: two faces of the same medal.\u00a0J Cardiothorac Vasc Anesth. 2021;35(11):3223\u201331.","DOI":"10.1053\/j.jvca.2021.05.029"},{"issue":"7","key":"3652_CR5","first-page":"74","volume":"8","author":"I Vendramin","year":"2021","unstructured":"Vendramin I, Lechiancole A, Piani D, Nucifora G, Benedetti G, Sponga S, et al. Use of sutureless and sutureless prostheses in challenging reoperations. J Cardiovasc Dev Dis. 2021;8(7):74.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"6","key":"3652_CR6","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1053\/j.jvca.2008.08.004","volume":"22","author":"S Salis","year":"2008","unstructured":"Salis S, Mazzanti VV, Merli G, Salvi L, Tedesco CC, Veglia F, Sisillo E. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22(6):814\u201322. https:\/\/doi.org\/10.1053\/j.jvca.2008.08.004. (Epub 2008 Oct 22 PMID: 18948034).","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"3652_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijsu.2010.10.007","volume":"9","author":"N Al-Sarraf","year":"2011","unstructured":"Al-Sarraf N, Thalib L, Hughes A, Houlihan M, Tolan M, Young V, McGovern E. Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients. Int J Surg. 2011;9(1):104\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2010.10.007. (Epub 2010 Oct 20 PMID: 20965288).","journal-title":"Int J Surg"},{"key":"3652_CR8","doi-asserted-by":"publisher","unstructured":"White A., Bozso S.J., Lakey O., et al. Sutureless valves versus conventional tissue valves for aortic valve replacement [epub ahead of print] J Thorac Cardiovasc Surg. 2020.\u00a0https:\/\/doi.org\/10.1016\/j.jtcvs.2020.06.022.","DOI":"10.1016\/j.jtcvs.2020.06.022"},{"issue":"3","key":"3652_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jtcvs.2020.11.162","volume":"161","author":"T Fischlein","year":"2021","unstructured":"Fischlein T, Folliguet T, Meuris B, Shrestha ML, Roselli EE, McGlothlin A, Heimansohn D. Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis. J Thoracic Cardiovasc Surg. 2021;161(3):920\u201332.","journal-title":"J Thoracic Cardiovasc Surg"},{"issue":"2","key":"3652_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2459\/JCM.0000000000001095","volume":"22","author":"E Mikus","year":"2021","unstructured":"Mikus E, Calvi S, Tavazzi L, Brega C, Tripodi A, Pin M, Manfrini M, Zucchetta F, Tenti E, Albertini A. Pacemaker need after sutureless aortic valve replacement: the role of the learning curve. J Cardiovasc Med (Hagerstown). 2021;22(2):133\u20138. https:\/\/doi.org\/10.2459\/JCM.0000000000001095. (PMID: 33021519).","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"3652_CR11","doi-asserted-by":"publisher","unstructured":"Kaneko T, Vassileva CM, Englum B, Kim S, Yammine M, Brennan M, Suri RM, Thourani VH, Jacobs JP, Aranki S. Contemporary Outcomes of Repeat Aortic Valve Replacement: A Benchmark for Transcatheter Valve-in-Valve Procedures. Ann Thorac Surg. 2015 Oct;100(4):1298\u2013304; discussion 1304.\u00a0\u00a0https:\/\/doi.org\/10.1016\/j.athoracsur.2015.04.062. Epub 2015 Jul 21. PMID: 26209480.","DOI":"10.1016\/j.athoracsur.2015.04.062"},{"issue":"2","key":"3652_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/jcm12020541.PMID:36675469;PMCID:PMC9866823","volume":"12","author":"F Formica","year":"2023","unstructured":"Formica F, Gallingani A, Tuttolomondo D, Hernandez-Vaquero D, D\u2019Alessandro S, Pattuzzi C, \u00c7elik M, Singh G, Ceccato E, Niccoli G, Lorusso R, Nicolini F. Redo Surgical Aortic Valve Replacement versus Valve-In-Valve Transcatheter Aortic Valve Implantation: A Systematic Review and Reconstructed Time-To-Event Meta-Analysis. J Clin Med. 2023;12(2):541. https:\/\/doi.org\/10.3390\/jcm12020541.PMID:36675469;PMCID:PMC9866823.","journal-title":"J Clin Med"},{"issue":"1","key":"3652_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14503\/THIJ-16-6092.PMID:29556145;PMCID:PMC5832078","volume":"45","author":"MO Hanedan","year":"2018","unstructured":"Hanedan MO, Yuruk MA, Parlar AI, Ziyrek U, Arslan AK, Sayar U, Mataraci I. Sutureless versus Conventional Aortic Valve Replacement: Outcomes in 70 High-Risk Patients Undergoing Concomitant Cardiac Procedures. Tex Heart Inst J. 2018;45(1):11\u20136. https:\/\/doi.org\/10.14503\/THIJ-16-6092.PMID:29556145;PMCID:PMC5832078.","journal-title":"Tex Heart Inst J"},{"issue":"3","key":"3652_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jocs.16223","volume":"37","author":"MY Salmasi","year":"2022","unstructured":"Salmasi MY, Ramaraju S, Haq I, Mohamed B, R. A., Khan, T., Oezalp, F., \u2026 & Raja, S. G. Sutureless technology versus conventional sutured bioprostheses in aortic valve replacement. J Card Surg. 2022;37(3):640\u201355.","journal-title":"J Card Surg"},{"issue":"4","key":"3652_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.21037\/acs.2020.04.01.PMID:32832413;PMCID:PMC7415697","volume":"9","author":"I Coti","year":"2020","unstructured":"Coti I, Haberl T, Scherzer S, Werner P, Shabanian S, Kocher A, Laufer G, Andreas M. Outcome of sutureless aortic valves: long-term experience after 700 implants. Ann Cardiothorac Surg. 2020;9(4):314\u201321. https:\/\/doi.org\/10.21037\/acs.2020.04.01.PMID:32832413;PMCID:PMC7415697.","journal-title":"Ann Cardiothorac Surg"},{"issue":"3","key":"3652_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/CIRCULATIONAHA.117.028783","volume":"136","author":"N Glaser","year":"2017","unstructured":"Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Prosthetic valve endocarditis after surgical aortic valve replacement. Circulation. 2017;136(3):329\u201331.","journal-title":"Circulation"},{"issue":"9","key":"3652_CR17","doi-asserted-by":"publisher","first-page":"774189","DOI":"10.3389\/fcvm.2022.774189.PMID:35391848;PMCID:PMC8980357","volume":"22","author":"A \u00d6ner","year":"2022","unstructured":"\u00d6ner A, Hemmer C, Alozie A, L\u00f6ser B, Dohmen PM. Introduction of the Sutureless Aortic Valve System Use in Elderly Patients With Endocarditis. Front Cardiovasc Med. 2022;22(9):774189. https:\/\/doi.org\/10.3389\/fcvm.2022.774189.PMID:35391848;PMCID:PMC8980357.","journal-title":"Front Cardiovasc Med"},{"key":"3652_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/24748706.2019.1588565","volume":"3","author":"I Cummings","year":"2019","unstructured":"Cummings I, Murphy MO, Pepper JR, Rosendahl UP, Quarto C, Asimakopoulos G. Sutureless Aortic Valve Replacement (AVR) for Prosthetic Valve Endocarditis: A Single Centre Experience. Structural Heart. 2019;3:216.","journal-title":"Structural Heart"},{"issue":"3","key":"3652_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/icvts\/ivy085","volume":"27","author":"A Salsano","year":"2018","unstructured":"Salsano A, Giacobbe DR, Sportelli E, Olivieri GM, Natali R, Prevosto M, Santini F. Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis. Interact Cardiovasc Thoracic Surg. 2018;27(3):328\u201335.","journal-title":"Interact Cardiovasc Thoracic Surg"},{"key":"3652_CR20","doi-asserted-by":"publisher","first-page":"844876","DOI":"10.3389\/fcvm.2022.844876","volume":"9","author":"T Fischlein","year":"2022","unstructured":"Fischlein T, Caporali E, Asch FM, Vogt F, Pollari F, Folliguet T, Lorusso R. Hemodynamic performance of sutureless vs conventional bioprostheses for aortic valve replacement: the 1-year core-lab results of the randomized PERSIST-AVR trial. Frontiers in cardiovascular medicine. 2022;9:844876.","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"1","key":"3652_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13019-023-02273-7","volume":"18","author":"J Jolliffe","year":"2023","unstructured":"Jolliffe J, Moten S, Tripathy A, Skillington P, Tatoulis J, Muneretto C, Goldblatt J. Perceval valve intermediate outcomes: a systematic review and meta-analysis at 5-year follow-up. J Cardiothor Surg. 2023;18(1):129.","journal-title":"J Cardiothor Surg"},{"key":"3652_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.xjtc.2022.02.025","volume":"13","author":"AS Dhanekula","year":"2022","unstructured":"Dhanekula AS, Nishath T, Aldea GS, Burke CR. Use of a sutureless aortic valve in reoperative aortic valve replacement. JTCVS techniques. 2022;13:31\u20139.","journal-title":"JTCVS techniques"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03652-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:16:36Z","timestamp":1704298596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03652-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3652"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03652-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3276639\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study, the requirement for ethical approval was waivered by the Research Ethics Office at the Royal Brompton and Harefield Foundation Trust","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"For this type of study consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}